• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Technology Events 2022-2023
  • Sponsored Post
    • Make a Contribution
  • Technology Markets
    • Venture Capital
  • About
  • Contact

Phase 1 Clinical Trial of Zika Vaccine Candidate

November 28, 2017 By admin Leave a Comment

In recent years, the Zika virus has had a devastating impact, spreading across more than 84 countries, territories or subnational areas, including the U.S. In February 2016, the World Health Organization (WHO) declared the Zika outbreak to be a Public Health Emergency of International Concern (PHEIC) and the Centers for Disease Control and Prevention (CDC) elevated its response efforts to its highest level (Level 1). Although WHO has since declared an end to the PHEIC,6 Zika continues to pose a significant threat to public health, especially for pregnant women, and a vaccine is still needed. Takeda was selected by BARDA in September 2016 to develop a vaccine to support the Zika response effort in the U.S. and affected regions around the world.

Takeda Pharmaceutical Company Limited today announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a Phase 1 clinical trial, approximately 15 months after Takeda received a contract to develop a Zika vaccine from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA).

The randomized, placebo-controlled, double-blind trial is designed to evaluate the safety and immunogenicity of the investigational vaccine candidate in 240 male and female subjects between the ages of 18 and 49. The Phase 1 trial also will assess several dose levels of the vaccine candidate to support the progression of TAK-426 into future studies.2 The trial will take place in the continental U.S. and U.S. territories and is being conducted under a U.S. Investigational New Drug (IND) application.

Given the public health threat posed by Zika, Takeda mobilized a multifunctional team immediately following signature of the contract with BARDA and has prioritized all aspects of the development program, enabling the Phase 1 trial to start within 15 months of funding. Initial data from ZIK-101 are expected in 2018, and, if available Phase 1 data support it, Takeda will work toward initiating Phase 2 studies as soon as possible.

Filed Under: Tech Tagged With: Zika vaccine

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

Demand for refurbished containers is insatiable
RealPage® Releases 2022 Market-Rate Apartment Affordability Report
Event Calendar
Europe’s Electricity Mix
How to sell across a variety of channels
European Market for Veterinary Antibiotics
When synthetic biology will disrupt an industry?

Market Research Media

How do marketers collect data?
Russia’s default on its foreign debt is around the corner
Qutrit.app: Qutrits are at the cutting edge of quantum computing
PublicDomain.ai: Public Domain Meets AI
Worldwide government IT spending is forecast to total $565.7 billion in 2022, an increase of 5% from 2021
Gaming-Disorder.com: Gaming disorder is now recognised by the World Health Organisation
NoSQLdatabase.com: SQL versus NoSQL overview

Secondary Sidebar

Tech Events

Bid Ops to Host Optimal ’22 Conference, March 23 – 24, 2022 in New York City
Powerful Keynote Speakers, Musical Headliners Announced for Ignite 2021 Logistics Tech Conference, August 3-5, 2021, San Antonio
Fira de Barcelona celebrates the extension of MWC Barcelona until 2030
DVCon U.S. 2023 will be held February 27-March 2, 2023, at the Doubletree Hotel in San Jose, California
MWC is back and taking place on 28 June – 1 July 2021 in Barcelona

Venture Capital

NEA leads $70 M USD Series C round in Indonesian Social Commerce Platform, Super
ZeroAvia Secures Additional $30 Million in Funding from IAG, Barclays, NEOM & AENU
wefox Closes US$400m Series D Round at US$4.5bn Post-Money Valuation
Passthrough Raises $5M To Simplify The Fund Closing Process
Biotech companies have received significant VC funding in the past three years

Footer

Recent Posts

  • Williams Invests in Technology to Generate Zero-Emission Hydrogen with Natural Gas
  • Nuclear power is overall one of the least deadly sources of energy
  • Postal Service Modernization Enables Expanded Electric Vehicle Opportunity
  • Toshiba Materials in Major Investment to Increase Silicon Nitride Ball Production Capacity
  • Ravn Alaska Orders 30 Hydrogen-Electric Engines from ZeroAvia
  • Sisvel Launches a Patent Pool on Wi-Fi 6
  • U.S. solar manufacturing missing a window of opportunity
  • General Atomics Advances Fusion Technology with Silicon Carbide (SiC)–Based Materials
  • Berge Bulk vessels to receive Anemoi Rotor Sails in its move towards a zero-emission fleet
  • BIRD – Israel-U.S. Binational Industrial R&D Foundation to invest $7.9 million in 9 new projects: The approved projects, with an overall budget of $20 million, involve innovations in the areas of Drones, Energy Efficiency, Environment Protection, Medical Devices, Pharma, Software and AI

App Coding

Software can be classified into two categories
Amazon MWS Integration from Celigo Now Available on SAP® Store
monday.com Adds Built-In Monetization Solution to the apps marketplace
Coder Announces First Multi-Cloud, Multi-Compute Integrated Development Environment Platform
Dynamic forms for your React app

API Coding

LeadDev London! The event for engineering leaders
Difference between REST and GraphQL
DataGrail Launches API & Agent to Automate DSR Fulfillment Across All Internal Data Systems, Saving Companies Weeks of Engineering Time
Types of API Testing
What is an API Gateway?

Blockchaining

What is a blockchain domain?
KuCoin Ventures Invests in Joyride Games, Inc., a Web3 Publishing Platform for Game Creators, Which Will Be Supported By KuCoin’s $100 Million Creators Fund
Venture Capital Firms Target African Blockchain Projects
Bit.Store Platform Launches Social-Fi Collaborative Investment
Blockchain.com and Unstoppable Domains Introduce .blockchain, First Branded Domain Name

Event Calendar

2021 ICMA Card Manufacturing & Personalization EXPO, May 17-20, 2021, Renaissance Orlando at SeaWorld, Orlando, Florida
Japan Wind Energy 2022 Conference & Exhibition (JWE2022), October 11-12, 2022, Yokohama, Japan
Korea International Construction & Industrial Safety Expo 2022, October 19-21, 2022, KINTEX, Goyang, Korea
BIO KOREA 2020 International Convention to Go Virtual, May 18-23 2020
Gulfood 2022, the world’s largest food and beverage B2B event, February 13-17, 2022, Dubai World Trade Center

Copyright © 2022 Technologies.org

Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT